You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine

Article info

Article menu
Immunotherapy biomarkers
Original research
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine

Authors

  • Carla Faria Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, France PubMed articlesGoogle scholar articles
  • Fabien Gava Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, France PubMed articlesGoogle scholar articles
  • Pauline Gravelle Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, FranceDepartment of Pathology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Juan Garcia Valero Department of Hemato-Oncology, IDIBAPS, Barcelona, SpainCentro de Investigación Biomédica en Red-Oncología (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Celia Dobaño-López Department of Hemato-Oncology, IDIBAPS, Barcelona, SpainCentro de Investigación Biomédica en Red-Oncología (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Nathalie Van Acker Department of Pathology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, FranceImag’IN Platform, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Cathy Quelen Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, FranceDepartment of Pathology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Gael Jalowicki IUCT-Oncopole, Toulouse, FranceDepartment of Pathology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Renaud Morin IMACTIV3D, Toulouse, France PubMed articlesGoogle scholar articles
  • Cédric Rossi Department of Hematology, Hôpital François Mitterrand and U1231 INSERM, Dijon, France PubMed articlesGoogle scholar articles
  • Jean-Michel Lagarde IMACTIV3D, Toulouse, France PubMed articlesGoogle scholar articles
  • Jean-Jacques Fournié Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, France PubMed articlesGoogle scholar articles
  • Loïc Ysebaert Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, FranceDepartment of Hematology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Camille Laurent Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, FranceDepartment of Pathology, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, FranceImag’IN Platform, Institut Universitaire du Cancer de Toulouse, CHU Toulouse, Toulouse, France PubMed articlesGoogle scholar articles
  • Patricia Pérez-Galán Department of Hemato-Oncology, IDIBAPS, Barcelona, SpainCentro de Investigación Biomédica en Red-Oncología (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Christine Bezombes Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, FranceIUCT-Oncopole, Toulouse, FranceLaboratoire d’Excellence 'TOUCAN-2', Toulouse, FranceInstitut Carnot Lymphome CALYM, Pierre-Bénite, France PubMed articlesGoogle scholar articles

Citation

Faria C, Gava F, Gravelle P, et al
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine
Journal for ImmunoTherapy of Cancer 2023;11:e007156. doi: 10.1136/jitc-2023-007156
Online issue publication 
October 29, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.